These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 31099778)
1. [Variability of the MIR196A2 Gene as a Risk Factor in Primary-Progressive Multiple Sclerosis Development]. Kiselev IS; Kulakova OG; Baulina NM; Bashinskaya VV; Popova EV; Boyko AN; Favorova OO Mol Biol (Mosk); 2019; 53(2):282-289. PubMed ID: 31099778 [TBL] [Abstract][Full Text] [Related]
2. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability. Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878 [TBL] [Abstract][Full Text] [Related]
3. Variants of MicroRNA Genes: Gender-Specific Associations with Multiple Sclerosis Risk and Severity. Kiselev I; Bashinskaya V; Kulakova O; Baulina N; Popova E; Boyko A; Favorova O Int J Mol Sci; 2015 Aug; 16(8):20067-81. PubMed ID: 26305248 [TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of MIR21 in CD4+ T cells from patients with relapsing-remitting multiple sclerosis associates with lower miRNA-21 levels and concomitant up-regulation of its target genes. Ruhrmann S; Ewing E; Piket E; Kular L; Cetrulo Lorenzi JC; Fernandes SJ; Morikawa H; Aeinehband S; Sayols-Baixeras S; Aslibekyan S; Absher DM; Arnett DK; Tegner J; Gomez-Cabrero D; Piehl F; Jagodic M Mult Scler; 2018 Sep; 24(10):1288-1300. PubMed ID: 28766461 [TBL] [Abstract][Full Text] [Related]
5. The pathology of primary progressive multiple sclerosis. Brück W; Lucchinetti C; Lassmann H Mult Scler; 2002 Apr; 8(2):93-7. PubMed ID: 11990878 [TBL] [Abstract][Full Text] [Related]
6. Allelic expression and interleukin-2 polymorphisms in multiple sclerosis. Matesanz F; Fedetz M; Collado-Romero M; Fernández O; Guerrero M; Delgado C; Alcina A J Neuroimmunol; 2001 Sep; 119(1):101-5. PubMed ID: 11525806 [TBL] [Abstract][Full Text] [Related]
7. miRNA polymorphisms (miR‑146a, miR‑149, miR‑196a2 and miR‑499) are associated with the risk of coronary artery disease. Sung JH; Kim SH; Yang WI; Kim WJ; Moon JY; Kim IJ; Cha DH; Cho SY; Kim JO; Kim KA; Kim OJ; Lim SW; Kim NK Mol Med Rep; 2016 Sep; 14(3):2328-42. PubMed ID: 27430349 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of apoptosis-related genes: Fas (CD94), FasL (CD178) and TRAIL polymorphisms in Iranian multiple sclerosis patients. Mohammadzadeh A; Pourfathollah AA; Sahraian MA; Behmanesh M; Daneshmandi S; Moeinfar Z; Heidari M J Neurol Sci; 2012 Jan; 312(1-2):166-9. PubMed ID: 21864851 [TBL] [Abstract][Full Text] [Related]
9. Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosis. Koch MW; Ilnytskyy Y; Golubov A; Metz LM; Yong VW; Kovalchuk O Eur J Neurol; 2018 Apr; 25(4):651-658. PubMed ID: 29316044 [TBL] [Abstract][Full Text] [Related]
10. Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis. Goertsches R; Baranzini SE; Morcillo C; Nos C; Camiña M; Oksenberg JR; Montalban X; Comabella M Mult Scler; 2008 Apr; 14(3):412-4. PubMed ID: 18208870 [TBL] [Abstract][Full Text] [Related]
12. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. Hensiek AE; Sawcer SJ; Feakes R; Deans J; Mander A; Akesson E; Roxburgh R; Coraddu F; Smith S; Compston DA J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):184-7. PubMed ID: 11796767 [TBL] [Abstract][Full Text] [Related]
13. An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis. McDonnell GV; Kirk CW; Hawkins SA; Graham CA J Neurol Sci; 2000 May; 176(1):4-12. PubMed ID: 10865086 [TBL] [Abstract][Full Text] [Related]
14. Genetic burden of common variants in progressive and bout-onset multiple sclerosis. Sorosina M; Brambilla P; Clarelli F; Barizzone N; Lupoli S; Guaschino C; Osiceanu AM; Moiola L; Ghezzi A; Coniglio G; Patti F; Mancardi G; Manunta P; Glorioso N; Guerini FR; Bergamaschi R; Perla F; ; ; Martinelli V; Cusi D; Leone M; Comi G; D'Alfonso S; Martinelli-Boneschi F Mult Scler; 2014 Jun; 20(7):802-11. PubMed ID: 24277324 [TBL] [Abstract][Full Text] [Related]
15. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain. Ramil E; Sánchez AJ; González-Pérez P; Rodríguez-Antigüedad A; Gómez-Lozano N; Ortiz P; Arroyo R; De las Heras V; Vilches C; García-Merino A Mult Scler; 2010 Feb; 16(2):139-46. PubMed ID: 20007426 [TBL] [Abstract][Full Text] [Related]
16. Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis. Schrijver HM; van As J; Crusius JB; Dijkstra CD; Uitdehaag BM Mediators Inflamm; 2003 Apr; 12(2):89-94. PubMed ID: 12775358 [TBL] [Abstract][Full Text] [Related]
17. Natural history of multiple sclerosis: a unifying concept. Confavreux C; Vukusic S Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308 [TBL] [Abstract][Full Text] [Related]
19. The p150 subunit of dynactin (DCTN1) gene in multiple sclerosis. Münch C; Meyer R; Linke P; Meyer T; Ludolph AC; Haas J; Hemmer B Acta Neurol Scand; 2007 Oct; 116(4):231-4. PubMed ID: 17824900 [TBL] [Abstract][Full Text] [Related]
20. A polymorphism in the repetitive (TGGA)n sequence 5' to the human myelin basic protein gene in Italian multiple sclerosis patients. Guerini FR; Losciale L; Mediati M; Speciale L; Mancuso R; Saresella M; Calvo MG; Caputo D; Ferrante P J Neurovirol; 2000 May; 6 Suppl 2():S28-32. PubMed ID: 10871781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]